Clinical Differentiation Oralucent offers a unique, clinically validated light therapy toothbrush platform with AI-modulated blue and red LED phototherapy, backed by peer-reviewed research from UPenn, Columbia, and NASA, providing a compelling differentiator for dental professionals seeking advanced home care solutions.

Professional Partnerships Active engagement with dentists, hygienists, periodontists, orthodontists, and DSO networks as resellers and referring affiliates creates recurring revenue opportunities for practices while expanding patient access to the platform.

High Traction Strong market momentum is evidenced by over 8,000 customers and 11,000 devices in market, with double-digit YoY growth, low return rate, and substantial consumable repeat potential, signaling ongoing demand and potential for upsell of consumables and data-driven services.

Financial & Growth Revenue range of 25–50 million with plans to raise convertible notes ahead of a Series A targeted for late 2026 indicates readiness for strategic investments, further product development, and a connected data platform expansion to capture a larger addressable market.

Market Positioning Addressing links between periodontal health and systemic conditions positions Oralucent within growing wellness and preventive care trends, offering a tangible value proposition to health systems, insurers, and patients seeking long-term oral and systemic health benefits.